v3.24.3
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Product Revenue
Product Cost of Sales
Gross Income
General and Administrative Expenses 1,104,130 1,334,690 3,192,762 4,202,594
Research and Development Expenses 707,747 1,912,322 2,307,789 4,907,196
Stock Based Compensation Expenses 13,762 595,576 970,754 2,341,915
Series F Warrant Issuance Expenses 762,834
Series F-1 Warrant Issuance Expenses 539,097
Series G Warrant Issuance Expenses 969,505
Loss from Operations (1,825,639) (3,842,588) (7,979,907) (12,214,539)
Other (Income) Expenses        
Interest and Dividend Income (163,951) (139,056) (203,405) (339,731)
(Gain)/Loss on Sale of Marketable Securities (551) 500 (651) 714
Change in fair value of Marketable Securities (4,746) (2,324) (3,771) 371
Change in fair value of Derivatives Liabilities 356,000 (2,566,900) 367,000 (2,251,700)
Change in fair value of Warrant Liabilities 17,000 (5,356,000) 4,410,000 (8,166,000)
Loss on issuance of Series F-1 Convertible Preferred Stock 3,737,000
Loss on issuance of Series G Convertible Preferred Stock 5,109,000
Casualty Loss/(Gain) (100,000) 178,198 (100,000) 178,198
Total Other (Income)/Expense 103,752 (7,885,582) 13,315,173 (10,578,148)
Income/(Loss) Before Income Tax (1,929,391) 4,042,994 (21,295,080) (1,636,391)
Income Tax Benefit/(Provision)
Net Income/(Loss) (1,929,391) 4,042,994 (21,295,080) (1,636,391)
Preferred Stock Dividends 751,052 1,158,051 2,730,259 1,690,180
Net Income/(Loss) Attributable to Common Stockholders $ (2,680,443) $ 2,884,943 $ (24,025,339) $ (3,326,571)
Basic net income/(loss) per common share $ (1.11) $ 1.84 $ (10.49) $ (2.28)
Diluted net income/(loss) per common share $ (1.11) $ 0.37 $ (10.49) $ (2.28)
Weighted average basic common stock outstanding 2,415,089 1,564,275 2,290,962 1,456,327
Weighted average diluted common stock outstanding 2,415,089 7,818,886 2,290,962 1,456,327

Source